Suppr超能文献

巨大肝细胞癌伴肝外侧支动脉成功采用多学科治疗包括腹腔镜血管离断术治疗:病例报告。

Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report.

机构信息

Department of Surgery, Yamaga City Medical Center, 511, Yamaga, Kumamoto, 861-0593, Japan.

Department of Radiology, Yamaga City Medical Center, Kumamoto, Japan.

出版信息

Clin J Gastroenterol. 2021 Feb;14(1):251-257. doi: 10.1007/s12328-020-01286-2. Epub 2020 Nov 12.

Abstract

Multidisciplinary treatment is recommended for the management of patients with advanced hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding arteries with laparotomy have been introduced for HCC. We herein newly develop laparoscopic devascularization (LDEV) to continue transarterial chemoembolization (TACE) for HCC with extrahepatic collateral arteries. A 74-year-old man with multiple huge HCC (4 tumors, 18 cm in diameter) and poor liver function (non-alcoholic steatohepatitis, Child-Pugh score 7) was treated with 6 times of chemoembolization in combination with LDEV, 3 times of ablation therapies, and lenvatinib therapy. His tumor markers were triple positive (AFP, 12,906.5 ng/ml; PIVKA-II, 491,743 mAU/ml; AFP-L3, 91.8%) before treatments; however, they all returned to normal limits. Complete response was achieved according to the modified RECIST criteria. Unfortunately, he died 6 months after the final treatment with no recurrence of HCC due to the postoperative complication of primary lung cancer. LDEV is a useful tool to continue effective TACE, and multidisciplinary treatment including chemoembolization and LDEV can cure advanced HCC patients with extrahepatic collaterals and impaired liver function.

摘要

多学科治疗被推荐用于晚期肝细胞癌(HCC)患者的管理。一些剖腹手术中肝外供养动脉的多学科治疗已经被引入到 HCC 的治疗中。我们在此新开发了腹腔镜血管离断术(LDEV),以继续对有肝外侧支循环的 HCC 进行经动脉化疗栓塞(TACE)。一名 74 岁男性患有多个巨大 HCC(4 个肿瘤,直径 18cm)和肝功能不佳(非酒精性脂肪性肝炎,Child-Pugh 评分 7),接受了 6 次化疗栓塞联合 LDEV、3 次消融治疗和仑伐替尼治疗。他的肿瘤标志物在治疗前均为三阳性(AFP,12906.5ng/ml;PIVKA-II,491743mAU/ml;AFP-L3,91.8%);但都恢复到正常范围。根据改良 RECIST 标准,达到完全缓解。不幸的是,由于原发性肺癌的术后并发症,他在最后一次治疗后 6 个月死亡,且 HCC 没有复发。LDEV 是继续有效 TACE 的有用工具,包括化疗栓塞和 LDEV 的多学科治疗可以治愈有肝外侧支和肝功能受损的晚期 HCC 患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验